Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Global Regulatory News (JARA)

Share Price Information for Jpmorgan Global (JARA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 74.40
Bid: 73.00
Ask: 75.00
Change: 0.60 (0.82%)
Spread: 2.00 (2.74%)
Open: 72.40
High: 74.40
Low: 72.40
Prev. Close: 73.40
JARA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Net Asset Value and Update

24 Dec 2020 07:00

RNS Number : 7445J
JPMorgan Global Core Real Assets Ld
24 December 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CORE REAL ASSETS LIMITED

 

QUARTERLY NET ASSET VALUE AND UPDATE

 

 

Legal Entity Identifier: 549300D8JHZTH6GI8F97

 

JPMorgan Global Core Real Assets Limited ("JARA" or "the Company") announces an unaudited Net Asset Value ("NAV") as at 30th November 2020 of 91.37 pence. Over the period there was also a dividend of 0.75 pence, paid on 30th November 2020 to shareholders on the register as at the close of business on 30th October 2020, bringing total return over the period to +1.24%.

 

Positive returns from the Company's liquid real asset strategies (circa 20% of NAV) over the quarter assisted performance. The listed real asset beta strategy (circa 10% of NAV) delivered a total return of 8.1% and the U.S. all-tranche REIT strategy (circa 10% of NAV) delivered a total return of 5.9%. The private U.S. Real Estate strategy1 (circa 19% of NAV) was a small negative contributor of -0.2%, making calendar YTD returns marginally negative for this strategy. The -0.29% depreciation of the US dollar versus sterling over the quarter delivered a small drag to performance.

 

 1 Latest performance statistics as at 30th September 2020

 

Investment Progress

The Company has so far invested approximately 99.5% of the net proceeds arising from its IPO and circa 74% of the total funds raised to date. 

 

An update on the progress of the C-share and related timetable will be published in the New Year. 

 

The Company aims to provide holders of the Ordinary Shares with a stable income and capital appreciation through exposure to a globally diversified portfolio of Core Real Assets in accordance with the Company's investment policy. The Company is seeking exposure to Core Real Assets through various real asset strategies, namely: Global Infrastructure, Global Real Estate, Global Transport and Global Liquid Real Assets. J.P. Morgan's Alternative Solutions Group has the primary responsibility for managing the Company's portfolio.

 

Income

Income generated from the underlying portfolio is estimated to be 0.77 pence per share, up from 0.43 pence per share over the previous period. The income derives from its investment in cash equivalent instruments, the Liquid Strategies, along with a distribution from the underlying Private Property Strategy and accrued income from the Transport and Infrastructure strategies over part of the period. JARA has delivered on its first year income target of 2-3 pence per share, having paid 3.0 pence per share in the first four dividends and management is confident in delivering the second full 12 month income target of 4-6 pence per share.

 

Issuance

During the period the Company issued no new shares, with 208,807,952 shares in issue.

 

Currency

The main currency exposures of the portfolio (including liquidity funds) are as follows and have diversified considerably since the last quarter end due to the drawdown into the other private strategies.

 

Currency

% of NAV

USD

83.6%

EUR

7.0%

GBP

2.9%

CAD

1.7%

AUD

1.5%

JPY

1.5%

HKD

0.5%

 

24th December 2020

 

Alison Vincent

JPMorgan Funds Limited - Company Secretary

Telephone 0207 742 4000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBLBDDRUDDGGX
Date   Source Headline
9th May 202410:04 amRNSHolding(s) in Company
8th May 20244:50 pmRNSTransaction in Own Shares
8th May 20247:00 amRNSMONTHLY PORTFOLIO UPDATE
7th May 20245:08 pmRNSTransaction in Own Shares
3rd May 20244:59 pmRNSTransaction in Own Shares
1st May 20244:25 pmRNSDividend Declaration
12th Apr 20245:10 pmRNSQuotedData's Weekly News & Interview
8th Apr 20247:00 amRNSMonthly Portfolio Update
3rd Apr 20246:25 pmRNSDirector/PDMR Shareholding
2nd Apr 20245:04 pmRNSBlock listing Interim Review
2nd Apr 20245:00 pmRNSClosed Period Announcement
25th Mar 20244:33 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSQuarterly Net Asset Value and Portfolio Update
15th Mar 20245:46 pmRNSDirector/PDMR Shareholding
1st Mar 20249:53 amRNSTotal Voting Rights
19th Feb 20244:54 pmRNSTransaction in Own Shares
16th Feb 20244:53 pmRNSTransaction in Own Shares
15th Feb 20245:09 pmRNSTransaction in Own Shares
13th Feb 20245:09 pmRNSTransaction in Own Shares
7th Feb 20245:00 pmRNSTransaction in Own Shares
7th Feb 20247:00 amRNSMonthly Portfolio Update
6th Feb 20244:51 pmRNSTransaction in Own Shares
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
5th Feb 20244:57 pmRNSTransaction in Own Shares
2nd Feb 20244:47 pmRNSTransaction in Own Shares
29th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
18th Jan 20247:00 amRNSDividend Declaration
5th Jan 20247:00 amRNSMONTHLY PORTFOLIO UPDATE
2nd Jan 202411:39 amRNSTotal Voting Rights
21st Dec 20237:00 amRNSNet Asset Value(s)
19th Dec 20234:23 pmRNSTransaction in Own Shares
1st Dec 202312:17 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSHalf-year Report
21st Nov 20237:00 amRNSLive Webinar hosted by Capital Access Group
10th Nov 20237:00 amRNSMonthly Net Asset Value
8th Nov 20235:00 pmRNSTransaction in Own Shares
7th Nov 20235:01 pmRNSTransaction in Own Shares
3rd Nov 20235:11 pmRNSTransaction in Own Shares
2nd Nov 20235:18 pmRNSTransaction in Own Shares
1st Nov 20235:20 pmRNSTransaction in Own Shares
1st Nov 202311:13 amRNSTotal Voting Rights
31st Oct 20235:07 pmRNSTransaction in Own Shares
30th Oct 20234:13 pmRNSTransaction in Own Shares
27th Oct 20235:12 pmRNSTransaction in Own Shares
26th Oct 20235:14 pmRNSTransaction in Own Shares
24th Oct 20235:18 pmRNSTransaction in Own Shares
18th Oct 20237:00 amRNSDividend Declaration
13th Oct 20234:48 pmRNSTransaction in Own Shares
12th Oct 20235:07 pmRNSTransaction in Own Shares
10th Oct 20235:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.